Candesartan Cilexetil/Hydrochlorothiazide Combination Treatment Versus High-Dose Candesartan Cilexetil Monotherapy in Patients With Mild to Moderate Cardiovascular Risk (CHILI Triple T)
Vascular Health and Risk Management
doi 10.2147/vhrm.s17004
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2011
Authors
Publisher
Informa UK Limited